Range Low Price High Price Comment
30 days $83.44 $92.16 Thursday, 28th Mar 2024 BMRN stock ended at $87.34. This is 1.43% less than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 2.31% from a day low at $86.65 to a day high of $88.66.
90 days $83.44 $99.25
52 weeks $76.02 $100.38

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2023-12-08 $94.27 $94.33 $92.36 $92.94 1 782 857
2023-12-07 $94.43 $95.41 $93.27 $94.94 2 432 035
2023-12-06 $92.24 $94.44 $92.24 $94.16 2 033 393
2023-12-05 $94.23 $94.86 $93.25 $93.61 2 715 283
2023-12-04 $92.50 $94.97 $92.27 $94.40 3 449 733
2023-12-01 $91.21 $92.50 $89.76 $92.42 2 224 338
2023-11-30 $89.85 $91.27 $89.34 $91.08 2 238 524
2023-11-29 $87.77 $89.81 $87.68 $89.74 1 617 326
2023-11-28 $88.41 $88.52 $87.47 $87.76 1 253 299
2023-11-27 $87.73 $89.11 $87.64 $88.60 1 803 562
2023-11-24 $88.69 $89.37 $88.14 $88.19 343 184
2023-11-22 $88.81 $88.81 $87.42 $88.42 1 304 999
2023-11-21 $87.46 $88.59 $86.87 $88.06 1 450 929
2023-11-20 $87.33 $88.57 $87.07 $87.53 3 122 375
2023-11-17 $87.18 $87.88 $86.71 $87.52 1 725 280
2023-11-16 $87.14 $88.20 $85.93 $87.21 2 875 501
2023-11-15 $84.78 $87.87 $84.41 $87.06 2 928 256
2023-11-14 $84.83 $85.89 $84.43 $84.86 1 402 144
2023-11-13 $83.18 $83.88 $82.55 $83.39 1 235 585
2023-11-10 $83.76 $84.65 $82.94 $83.98 2 515 763
2023-11-09 $85.65 $85.70 $83.61 $83.72 2 498 352
2023-11-08 $85.38 $85.99 $83.52 $85.51 2 575 482
2023-11-07 $82.88 $86.50 $81.92 $85.49 5 209 247
2023-11-06 $79.37 $79.37 $76.19 $76.22 2 010 441
2023-11-03 $80.16 $80.49 $79.05 $79.59 2 390 170
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT